Neuralink’s Blindsight implant has received FDA breakthrough status, aiming to restore sight by stimulating the visual cortex ...
An inherent principle of publication is that others should be able to replicate and build upon the authors' published claims. A condition of publication in a Nature Portfolio journal is that authors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback